Pharmaceutical Supply Chain: Navigating 2028 U.S. Drug Import Duties

The economic structure of the generic drug sector makes it uniquely vulnerable to trade levies. Unlike patent-protected brand-name drugs with high margins, generic drugs operate as low-margin commodities. Generic manufacturers compete almost entirely on unit cost. Therefore, even small shifts in overhead can determine whether a drug remains viable to manufacture. Imposing a 100% or…